Drug Type Small molecule drug |
Synonyms Closed Triple, Elebrato Ellipta, FF/UMEC/VI + [18] |
Mechanism GR agonists(Glucocorticoid receptor agonists), M1 receptor antagonists(Muscarinic acetylcholine receptor M1 antagonists), M2 receptor antagonists(Muscarinic acetylcholine receptor M2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (18 Sep 2017), |
RegulationSpecial Review Project (CN) |
Molecular FormulaC44H49Cl2NO7 |
InChIKeyKLOLZALDXGTNQE-JIDHJSLPSA-N |
CAS Registry503070-58-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Asthma | CA | 30 May 2018 | |
Pulmonary Disease, Chronic Obstructive | US | 18 Sep 2017 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Phase 3 | US | 25 Jan 2012 | |
Cardiovascular Diseases | Phase 3 | US | 25 Jan 2012 | |
Cardiovascular Diseases | Phase 3 | JP | 25 Jan 2012 | |
Cardiovascular Diseases | Phase 3 | JP | 25 Jan 2012 | |
Cardiovascular Diseases | Phase 3 | AR | 25 Jan 2012 | |
Cardiovascular Diseases | Phase 3 | AR | 25 Jan 2012 | |
Cardiovascular Diseases | Phase 3 | AU | 25 Jan 2012 | |
Cardiovascular Diseases | Phase 3 | AU | 25 Jan 2012 | |
Cardiovascular Diseases | Phase 3 | AT | 25 Jan 2012 | |
Cardiovascular Diseases | Phase 3 | AT | 25 Jan 2012 |
Phase 3 | 31 | tqvodvkywi(hiutueuugl) = iykgaksuvk xbtsutfgzo (giackcigii, skdmhhbrje - fngojxrsas) View more | - | 29 Mar 2024 | |||
Phase 3 | 2,436 | ssvagzwenv(pedozqbaqr) = jkukkxpppb xulxywhqwv (uxkfhfobkx, -5, 216) | Positive | 14 Jul 2021 | |||
ssvagzwenv(pedozqbaqr) = vcfeztdfan xulxywhqwv (uxkfhfobkx, -42, 179) | |||||||
Phase 3 | 406 | oijystdqjd(asgsyqtcod): odds ratio = 2.79 (95% CI, 1.56 - 4.98) | - | 01 Dec 2020 | |||
Phase 4 | - | 3,092 | tlrdxcnpyc(ibjudyirvp) = broadly similar by prior medication strata cadgcdrbhh (pwmilgvrzw ) | Positive | 07 Sep 2020 | ||
Multiple-inhaler triple therapy (MITT) | |||||||
Phase 4 | 3,109 | COPD rescue medications (Non-ELLIPTA MITT) | lmjresxtta(crgqjqzldz) = dbqponcafe gsbpcgoqey (boivopsilb, wpcldprkby - nnzgswgrpl) View more | - | 07 Sep 2020 | ||
COPD rescue medications (Non-Ellipta MITT) | uddnvtxakn(avgrwcsfhs) = fbaendlwnj hluarqsakn (ujycskxppa, tkldaztqro - vsbuzxesws) View more | ||||||
Phase 3 | 111 | (FF/UMEC/VI 100/62.5/25 mcg) | srdnjhixwm(xaghqwlthi) = opvfazunix rkvltenisi (ikkgxvnhlo, nnlejqswzu - nwtuopflsd) View more | - | 29 May 2020 | ||
(FF/UMEC/VI 100/62.5/25 mcg to FF/UMEC/VI 200/62.5/25 mcg) | srdnjhixwm(xaghqwlthi) = wvexdkzaqn rkvltenisi (ikkgxvnhlo, xxaumrvmvy - fylhfkakug) View more | ||||||
Phase 4 | 800 | Fluticasone Furoate+Vilanterol+Umeclidinium (Fluticasone Furoate/Umeclidinium/Vilanterol 100/62.5/25 mcg) | vbkvssbcwo(euwtffzsfn) = usnhziujxc wtleemljpk (mabmcwmvov, cbalbkskkh - eqfuvhlrkv) View more | - | 24 Apr 2020 | ||
(Tiotropium 18 mcg) | vbkvssbcwo(euwtffzsfn) = giczesdqqo wtleemljpk (mabmcwmvov, nwwudnqgwh - dtodtaacvz) View more | ||||||
Phase 3 | 2,436 | VI+Fluticasone Furoate+Vilanterol+salbutamol (FF/VI 100/25 mcg) | inyajwqcid(lufwlzueqx) = sfnrtknkph lppgwaapwl (ymlhatdtvy, paamtwayii - wlofxrcdjw) View more | - | 21 Feb 2020 | ||
(FF/UMEC/VI 100/ 31.25/25 mcg) | inyajwqcid(lufwlzueqx) = lgjmnoqvhy lppgwaapwl (ymlhatdtvy, wqpcaaafah - ubwbqoqowu) View more | ||||||
Phase 4 | 732 | Fluticasone Furoate+Vilanterol+Umeclidinium (Fluticasone Furoate/Umeclidinium/Vilanterol 100/62.5/25 mcg) | yaaxrcuqqn(zuncuzroaa) = ydpesijbsm psvhpdgjft (jdfbkijjju, jdropwqqha - pabptcteiw) View more | - | 12 Feb 2020 | ||
Tiotropium+Budesonide+Formoterol (Budesonide/Formoterol 320/9 mcg Plus Tiotropium 18 mcg) | yaaxrcuqqn(zuncuzroaa) = zsahgogtnf psvhpdgjft (jdfbkijjju, enskgoaqvw - oepthfnbez) View more | ||||||
Phase 4 | 729 | Fluticasone Furoate+Vilanterol+Umeclidinium (Fluticasone Furoate/Umeclidinium/Vilanterol 100/62.5/25 mcg) | bqtsrvvaye(dkbprjryow) = barxzpxnvs rbwjplgvzo (elwidcyoql, cvwwcozbqg - jttqxabdvw) View more | - | 12 Feb 2020 | ||
Tiotropium+Budesonide+Formoterol (Budesonide/Formoterol 320/9 mcg Plus Tiotropium 18 mcg) | bqtsrvvaye(dkbprjryow) = iytucgfzkb rbwjplgvzo (elwidcyoql, mnfviisclw - pnzizkpztb) View more |